Jazz spending spree has ups and downs


Jazz Pharmaceuticals has agreed with Aerial Bio Pharma to acquire the rights to ADX-N05, a drug designed to treat narcolepsy. The agreement sees an initial payment of $125 million (£76 million) in cash, plus up to $270 million dependent on development and revenue milestones. Aerial announced positive results for phase IIb trials of ADX-N05 and had been publicly seeking a buyer to oversee the next phase of the drug’s development.

However, Jazz’s proposed takeover of Italian drugmaker Gentium appears to be in jeopardy. Jazz had agreed with Gentium's board to acquire a controlling stake in the company in a deal that was initially valued at around $1 billion. The sale has been rejected by the company’s shareholders, who are now taking legal action against the board of Gentium on the grounds that they have undervalued the company and filed misleading and false documents with the Securities and Exchange Comission. In October 2013, Gentium received authorisation from the European commission to market DNA-based drug Defitelio (defibrotide), for treating severe hepatic veno-occlusive disease in patients undergoing haematopoietic stem cell transplants.

Both of these proposed transactions have increased ongoing speculation that Jazz is itself likely to become a target for further mergers and acquisitions activity, as it becomes more attractive to prospective buyers.


Related Content

Following her passion

11 January 2013 Research

news image

Veronique Gouverneur tells Marie Cote about fabulous fluorine and her next challenge

What are you afraid of?

29 October 2013 Feature

news image

The public’s mistrust of ‘chemicals’ will take great efforts to repair. Katharine Sanderson looks at the ‘c’-word

Most Read

Antimicrobial resistance will kill 300 million by 2050 without action

16 December 2014 News and Analysis

news image

UK report says resistance will cost global economy $100 trillion

Cutting edge chemistry in 2014

10 December 2014 Research

news image

We take a look back at the year's most interesting chemical science stories

Most Commented

Smart skin for prosthetic limbs senses heat and touch

12 December 2014 Research

news image

Ultra-thin plastic skin can bend and flex without affecting the skin's ability to detect stimuli

Chemistry behind the ‘blue man’ unlocked

1 November 2012 Research

news image

Biochemical model suggests that silver ions, not nanoparticles, cause a rare skin complaint